Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03987334
Other study ID # VR-NECKPAIN
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 9, 2019
Est. completion date March 31, 2023

Study information

Verified date June 2019
Source IRCCS San Raffaele
Contact Sandro Iannaccone, Dr
Phone +39 0226435734
Email iannaccone.sandro@hsr.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

VR-NECKPAIN is a two-arm, monocentric, single-blind, randomized controlled trial in Neck Pain patients.

The entire treatment consist in 12 sessions, each during 45 minutes, twice a week for 6 consecutive weeks.

Subjects will be evaluated ad baseline (T0) and after six weeks of rehabilitation (T1). There will also be a 3 months Follow-Up assessment (T2).

The total duration of study participation for each subject will be approximately 19 weeks, including evaluation at T0, treatment and evaluation at T1 and T2.

Individuals in the experimental group (VRT) will undergo a virtual reality-based sensorimotor rehabilitation. Control group (CT) subjects will undergo the same rehabilitation of VR subjects, in terms of intensity, time and type, but with the virtual reality turned off.


Description:

VR-NECKPAIN is a monocentric, single-blind, randomized controlled trial in Neck Pain patients.

Subjects will receive rehabilitation treatment twice a week, for six consecutive weeks. Subjects will be evaluated ad baseline (T0) and after six weeks of rehabilitation (T1). Also there will be a 3 months Follow-Up assessment (T2).

The total duration of study participation for each subject will be approximately 19 weeks, including evaluation at T0, treatment and evaluation at T1 and T2.

Individuals in the experimental group (VRT) will undergo a virtual reality-based sensorimotor rehabilitation. Control group (CT) subjects will undergo the same rehabilitation of VR subjects, in terms of intensity, time and type, but with the virtual reality turned off.

The study is conducted from March 2019 and the conclusion is planned to March 2023.

Patients with Neck Pain will be enrolled at the Department of Rehabilitation and Functional Recovery of San Raffaele Hospital, via Olgettina 60, Milan.

The treatment will last 45 minutes, 2 sessions per week for a total of 6 weeks. The first 15 minutes of treatment will consist, for each group, in manual therapy treatment, such as mobilization, manipulation, trigger-points treatment, tailored on the individual.

Subjects in the experimental Group (VRT) will undergo 30 minutes of motor control exercises using a virtual reality-based sensorimotor rehabilitation provided using the Virtual Reality Rehabilitation System (VRRS) of Khymeia Group. The equipment includes a computer workstation connected to a 6 degrees of freedom (DOF) motion-tracking system (Polhemus G4, Vermont, US), a high-resolution LCD displaying the virtual scenarios on a large screen and a software processing the motion data coming: from the receiver of the sensors end-effectors placed on the sternum and on the head through a helmet. The system has been found to reliably record head position and cervical range of motion among asymptomatic people as well as persistent neck pain patients.The VRRS allows the participant to perform the requested motor tasks, while the movement of the system's end-effector is simultaneously represented in a virtual scenario.

Control Group (CT) subjects will undergo the same treatment of VRT subjects in terms of intensity, time and type, but with the VR turned off.

In addition, all subjects will be educated in emphasizing self-management and return to normal function.

A blind assessor will be present in our study. In order to maintain him/her blind, treatments on patients will never take place in presence of the assessor.

Forty healthy subjects, matched for age and sex to the studied population, will also be enrolled in order to obtain normative data to compare with neck pain subjects.


Recruitment information / eligibility

Status Recruiting
Enrollment 72
Est. completion date March 31, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Adult individuals (18-70 years old);

- Neck Pain (Chronic Neck Pain or Whiplash);

- Normal vision or corrected vision.

Exclusion Criteria:

- Informed Consent negation;

- System infection or metabolic/neurological/muscular degenerative disorder;

- Cervical spinal pathology, fracture or surgery;

- Radiculopathy;

- Vestibular impairments;

- Epilepsy;

- Pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual Reality Treatment
Experimental Group (VRT) subjects will undergo Virtual Reality Motor Control exercises based on augmented feedback of their performance.
Control Group
Control Group (CT) subjects will undergo the same treatment of VRT subjects in terms of intensity, time and type, but with the VR turned off.

Locations

Country Name City State
Italy IRCSS Ospedale San Raffaele Milan MI

Sponsors (1)

Lead Sponsor Collaborator
IRCCS San Raffaele

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Neck Disability Index (NDI) The NDI is a self-report questionnaire used to determine how neck pain affects a patient's daily life and to assess the self-rated disability of patients with neck pain. The NDI consists of 10 questions in various domains: Pain Intensity, Personal care, Lifting, Reading, Headaches, Concentration, Work, Driving, Sleeping and Recreation. Each question contains six answer choices, scored from 0 (no disability) to 5 (complete disability). Total score is reported on a 0-50 scale. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Change in Numeric Rating Scale (NRS) The Numeric Rating Scale is a segmented numeric horizontal bar on which patients select a whole number (from 0 "no pain" to 10 "worst possible pain") that best reflects the intensity of their pain at rest and on movement. It has become a widely used instrument for pain screening and is ubiquitous as a screener in many health care environments. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Change in Neck and Pain Disability Scale (NPAD) The Neck and Pain Disability Scale is made by a 20 items measuring the intensity of pain and its interference with vocational, recreational, social and functional aspects of living and the presence and extent of associated emotional factors. Patients respond to each item by marking along a 10-cm visual analog scale. Item scores range from 0 to 5. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Change in Tampa Scale of Kinesiophobia (TSK) The Tampa Scale of Kinesiophobia is a 17 item questionnaire used to assess the subjective rating of kinesiophobia or fear of movement. The original questionnaire was developed to "discriminate between non-excessive fear and phobia among patients with chronic musculoskeletal pain". The scale was then found to be valid and reliable. Initially it was used in order to assess fear of movement related to chronic low back pain, but then it has been used for pain related to different parts of the body, including the cervical spine. The TSK is a self-completed questionnaire and the range of scores are from 17 to 68, where the higher scores indicate an increasing kinesiophobia. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Change in Active Range of Motion The distance and direction to which a bone joint can be extended. Range of motion is a function of the condition of the joints, muscles, and connective tissues involved. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Change in Conjunct Motion Conjunct motion consists in cervical movements in the associated planes relative to the primary movement plane. It may reflect protective postural control strategies. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Change in Jerk Movements Jerk Movements are the rate of changes in acceleration, a way to quantitatively evaluate smoothness of movements. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Changes in Joint Position Error (JPE) The JPE will be recorded as the difference in head orientation between the start position (positioned vertically by a physiotherapist) and the position after a target catching in a 8 different circle-direction with movements of 20°. Baseline (at recruitment/before intervention), Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
Secondary Patient Global Impression of Change (P-GIC) The Patient Global Impression of Change scale is recommended for use in chronic pain clinical trials as a core outcome measure of global improvement with treatment. The scale measures the change in patient's overall status since the beginning of the study on a scale of: 1 (very much improved); 2 (much improved); 3 (minimally improved); 4 (no change); 5 (minimally worse); 6 (much worse); and 7 (very much worse). This measure is a single-item rating by participants of their improvement with treatment during a clinical trial on a 7-point scale that ranges from 'very much improved' to 'very much worse' with 'no change' as the mid-point. The data provide a responsive and readily interpretable measure of participants' assessments of the clinical importance of their improvement or worsening over the course of a clinical trial. Post-Intervention (after 6 weeks rehabilitation), Follow-Up (after 3 months from completion of intervention)
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain